In summary, it can be stated that Esc peptides, particularly Esc(1-21)-1c do represent encouraging candidates for new strategies to treat Pseudomonas lung infection especially in CF patients, able to act not only as antibiotic agents but also as wound healing promoters and potentiators of CFTR with conductance defects (Figure 9). Here, CFTR is linked to cystic fibrosis.